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Abstract. The development of a wearable-based system for detecting difficulties 
in the daily lives of people with dementia would be highly useful in the day-to-
day management of the disease. To develop such a system, it would be necessary 
to identify physiological indicators of the difficulties, which can be identified by 
analyzing physiological datasets from people with dementia.  However, there is 
no such data available to researchers. As such, it is vital that data is collected and 
made available in future. In this paper we perform a review of past physiological 
data collection experiments conducted with people with dementia and evaluate 
the methods used at each stage of the experiment. Consideration is also given to 
the impacts and limitations imposed by the COVID-19 pandemic and lockdowns 
both on the people with dementia- such people being one of the most at risk and 
affected groups- and on the efficacy and safety of each of the methods. It is con-
cluded that the choice of method to be utilized in future data collection experi-
ments is heavily dependent on the type and severity of the dementia the partici-
pants are experiencing, and that the choice of remote or COVID-secure methods 
should be used during the COVID-19 pandemic; many of the methods reviewed 
could allow for the spread of the virus if utilized during a pandemic.  
Keywords: Dementia, wearable, data collection, COVID-19.  
1 Introduction  
Dementia is a used to describe a range of symptoms which arise from several progres-
sive neurodegenerative disorders which, through causing irreversible damage to neu-
rons of the brain, cause the loss of cognitive functioning [1]. This neuronal damage 
eventually causes the patient to experience and exhibit symptoms which inhibit their 
ability to perform tasks in their daily life. In 2018, there were 448,300 people recorded 
as having dementia in England alone [2] with the global number of cases being esti-
mated at approximately 50 million [3]. As of the writing of this paper, there is no cura-
tive treatment for dementia [4]. However, methods for the management of the disease 
are constantly improving with research and refinements in clinical practice, increasing 
the Quality of Life (QoL) and independence of people with dementia. However, care-
giver burden and patient fears of loss of independence remain high despite progress 
made [5, 6]. The advent of personalised healthcare and wearable computing to track 
health could provide hope for overcoming these problems, with a system that could 
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track and predict the difficulties of people with dementia and automatically intervene 
being feasible; personalised health systems already exist for other conditions [7-11].     
In previous work, we identified that one of the main problems in the development of 
such a system was there being no publicly available physiological data from people 
with dementia with which to develop machine learning based systems for identifying 
dementia-related symptoms and difficulties [12]. As such, it is vital that such data is 
collected and made available to researchers. However, the conducting of such data ex-
periments has been complicated by the emergence of COVID-19 and resulting lock-
downs. Dementia is one of the most common co-morbidities with COVID 19 [13], 
meaning that it is vital that people with dementia are shielded and prevented from un-
necessary contact. Therefore access to participants with dementia for data collection 
experiments is severely reduced [14]. However, this delay in research could lead to 
delays in finding better treatments and management techniques which could improve 
the quality of life for many dementia sufferers. As such, it is important the methods to 
be employed by future data collection experiments are carefully considered, with spe-
cial consideration being given to the impact of COVID 19 on those methods.  
In this paper, we review the methods used in past data collection experiments which 
aimed to collect physiological data which could be used to identify dementia related 
difficulties. We then discuss how the COVID-19 pandemic could potentially impact the 
tasks required to carry out such methods. This paper is novel as no existing literature 
could be found which reviewed the impact of COVID-19 on the conductance of phys-
iological data collection experiments with subjects with dementia. The rest of the paper 
is structured as follows. Section II describes the search methodology used to find pa-
pers. Section III elaborates on the various stages or elements of past studies and the 
methods involved at each, evaluating their efficacy and effectiveness. This section will 
also describe the difficulties COVID 19 could cause regarding those methods and pro-
pose potential solutions to those problems. Finally, section IV provides a conclusion.    
2 Methodology  
The literature search was performed on the online resources IEEE Xplore, ACM Digi-
tal, PubMed, Scopus, Web Of Science and Google Scholar, using pre-specified key-
words. Results were filtered to include journal and conference papers from January 
2015 to December 2020. A total 1514 results were returned. The title review inclusion 
criteria were that the title includes: the words “dementia”, “Alzheimer’s”, “cognitive 
impairment”, or the name of a BPSD or dementia symptom; the words monitoring, 
smart device, assistive device, system, technology, or the name of a sensors or physio-
logical feature. Excluded were studies whose title mention requirements elicitation, 
screening, diagnosis, smartphones, mobile applications, or social robots, and review 
papers.  All duplicate results were also removed. For abstract review, the inclusion cri-
teria were to include all studies which: are human studies; discuss the use of wearable 
devices as part of the system being tested. Excluded were studies which were: Purely 
smartphone-based; not focused on dementia and related difficulties, or behavioural and 
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psychological symptoms of dementia (BPSD); not including data collection; using de-
vices to locate missing persons; focusing on caregivers. In full paper screening, the 
inclusion criteria were to include studies which: include data collection experiments 
using people with dementia; provide sufficient details of methodology employed. Ex-
cluded were papers which: are inaccessible due to paywalls (due to financial con-
straints); containing data collection but with insufficient detail of methodology for 
meaningful critique. The methodology is illustrated in Figure 1. 
 
 
Figure 1. Search and review flow diagram 
3 Discussion  
3.1 Recruitment  
Recruitment is the process by which study participants are identified, approached, in-
formed, and asked to participate [15]. Recruitment was discussed in 14 papers [16-29]. 
Different recruitment methods are employed depending on the setting of the experiment 
and stage of dementia studied. In 2 papers, hospitals are used for recruitment [20, 21]. 
In one, the subjects were recruited as outpatients of the hospital, as the study focused 
on tracking behaviours in subjects in a residential settings [21]. In another paper, the 
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subjects were recruited as inpatients of the hospital, expected to remain in the hospital 
for 10 days [20]. One advantage of recruiting via hospitals is the high volume of patients 
admitted over any period of time, and thus, as in [20], it is easier to recruit large sample 
sizes over prolonged periods of time. Furthermore, the presence of trained healthcare 
professionals means that the patients can be medically and neuropsychological assessed 
with relative ease. Moreover, hospitals are often where the patient is diagnosed with 
dementia a, thus hospital recruitment could allow for recruitment of early stage demen-
tia patients [30]. However, COVID 19 is likely to make this channel more difficult to 
use. During the COVID-19 pandemic, hospitals have been in high demand. Several 
services have faced delays and cancellations to prevent hospitals becoming over-
whelmed [31, 32]. The number of people being diagnosed with dementia experienced 
a 4% drop in England in 2020 [33]. This reduces the number of potential participants. 
Furthermore, staff are often busy with increased patients during the pandemic, so it may 
be difficult to obtain permissions and co-operation from hospitals.  
Another channel for recruitment is dementia-specific care homes or residential insti-
tutions, as in 8 papers [22-29].One advantage of this is that the care home will contain 
many potential participants. However, people in care homes are often in the moderate 
to severe stage of dementia, so this channel may not be ideal for recruiting people in 
the early stages. Furthermore, COVID 19 has been prevalent in care homes, with care 
home residents experiencing one of the highest mortality risks of any group during the 
pandemic [34, 35]. As such, access to people in care homes may not be granted. Other 
methods of contacting and communicating with care home residents could be adopted 
to overcome this, such as video conferencing, however due to the age and impairment 
of many of the potential participants this solution will rely heavily on the aid of care 
home staff, who are experiencing increased workloads and stress during the pandemic.  
One channel for the recruitment of community-based subjects with dementia is com-
munity support and advocacy groups, being used in the Behavioural and Environmental 
Sensing and Intervention (BESI) study [17-19]. A similar channel is a dementia day-
care [16], where community-based dementia patients so that their caregivers can have 
a break. The support and advocacy groups are likely to be more useful for the recruit-
ment of people in the earlier stages of dementia [16]. Overall, the recruitment channel 
used in an experiment likely depends heavily on the setting of the experiment and the 
stage of dementia focused on, with hospital outpatient facilities and community support 
and advocacy groups being good recruitment channels for community-based experi-
ments and hospital inpatient facilities and nursing homes being good recruitment chan-
nels for hospital and care institution-based experiments. However, COVID 19 has 
caused a number of support groups to cease face-to-face meetings, and that could make 
it more difficult to contact potential participants and guardians about the study [32]. 
Therefore, remote communications are likely to provide the best methods for contacting 
potential participants during the pandemic, but the process may be much slower.  
3.2 Consent & assent acquisition  
The process for acquiring consent is specifically discussed in 9 papers [16, 20, 22-28]. 
Due to the subjects in all the studies in the 9 papers having some level of cognitive 
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decline, the informed written consent is obtained from a proxy who is the subject’s legal 
Power of Attorney (PoA) or guardian, usually a family member. In 8 papers, consent is 
primarily gained from the PoA, as the subjects are unable to consent [16, 22-28]. This 
is generally in the moderate to severe stages of dementia [15]. However, it is specified 
in 2 of those 8 papers that 1 subject is still able to consent, and as such their consent is 
obtained [25, 26]. In one paper, both the subject and PoA are asked for their consent 
for participation [20]. In 4 papers, it is specified that assent was gained from the subject, 
even if they were unable to give informed consent. For example, in [22-24] the partic-
ipant’s consent would be considered withdrawn if they refused to wear the device. In 
these cases, written consent was also acquired from a proxy, such as a PoA. To ensure 
that the consent was informed, before each experiment the PoA was given either writ-
ten, verbal or written and verbal information about the experiment, including the pro-
cedures and ways in which they can end the subject’s participation in the study should 
they later change their mind. The combination of written and verbal information is 
likely the best delivery method, as the written information can be referred back to, but 
the delivery of information verbally allows for the receiver to ask questions and seek 
clarification [15, 24]. In [24], written and verbal information was also given to the for-
mal caregivers of the subject’s, as they knew the subject well and thus would be able 
to provide input as to if the subject would be happy and safe to participate. Caregivers 
may also have to be asked for informed consent for their own participation, especially 
where the use of video cameras could lead to their own activities being recorded [15, 
22, 23, 25, 26]. Overall, it is clearly vital to obtain informed, written consent from the 
subject’s PoA, and assent of the subject to participate in the study should be taken into 
consideration. All stakeholders who are required to give consent should be given writ-
ten and verbal information about the experiment. They should also be given the oppor-
tunity to withdraw consent at any stage. Moreover, contacting potential participants to 
inform them of the study and give adequate information to make the informed decision 
to participate may be difficult due to disruptions during to the pandemic [36]. 
3.3 Physiological data collection  
Collection of physiological data is the central focus of the papers included [16-29, 37-
43]. 4 aspects are highlighted: physiological data features monitored; device used; 
length of experiment; deployment methods and durations.  
The selection of the device is heavily dependent upon the data features monitored, 
and  the usability of the device for participants. The most used device is a smartwatch 
or wrist-worn medium, utilised as the lone wearable device in 12 of the included papers 
[17-24, 29, 40-42]. Accelerometers are the most common sensor deployed on wrists, 
with all but two of the papers with wrist-worn devices employing accelerometers to 
track movement and activity [17-20, 22, 23, 29, 40-42]. Wrist worn devices are usable 
with participant in all stages of dementia. An advantage of these devices is they can 
allow for the tracking of upper limb movement as well as full body movement, unlike 
chest or waist-based mediums.  Wrist-worn mediums are also used in combination with 
other wearable devices too, with the most common combination being wrist and ankle 
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devices, as in 3 papers [25, 26, 44]. Two papers use wrist and ankle accelerometer de-
vices, allowing for the detection of upper body movement and leg movement [25, 26]. 
In 1 paper, an ankle sensor is the only to employ an accelerometer, as well as a GPS 
location monitor, while a wrist-worn device tracks EDA [43]. A smartwatch is also 
utilised in combination with a neck-worn microphone in 1 study to detect agitation [27]. 
In this study, an Android smartwatch is used to track the subjects’ HR and limb move-
ments. The data collected by the smartwatch correlated with the observed instance of 
agitation, indicating a high degree of accuracy. The combined use of 2 devices can 
increase the number of data features that can be collected, as in [27] and [43], or in-
crease the number of locations one can acquire that feature from, as in [25] and [26]. A 
drawback is that the management of 2 devices will be more complicated. Furthermore, 
the more  wearables in a system the more obtrusive and obstructive that system will be.  
The placement of sensors on the subject’s heel is used in 1 included paper, where 
the researchers are tracking the walking patterns of the participant to identify disorien-
tation [37]. The participant wears an Inertial Measurement Unit (IMU) and is asked to 
walk a route in a laboratory setting. The researchers then used the data from the IMU 
to calculate the acceleration of the subject’s foot, their movement duration and speed. 
Though deployment of a device on the heel is successful in this study, it has a limitation: 
a device deployed here is very limited as to the physiological data features it can track.    
In 1 included paper, a chest-worn device- the Zephyr BioHarness 3.0- is utilised to 
track HR data in subjects exhibiting PV [28]. The placement of the device on the chest 
allows for very accurate measurement of ECG, and the device had been verified as 
useable for elderly people with dementia [28]. However, this deployment medium can-
not measure things such as limb movement, and deployment of a device onto a  chest 
is somewhat invasive. Deployment of waist or hip worn devices is less invasive than 
on the chest and is utilised in 3 of the included papers [16, 38, 39]. In two of the papers, 
the sensor deployed at the hip is an accelerometer and in 1 paper the device deployed 
is a Bluetooth sensor, used to track the location of the participant in relation to environ-
mental Bluetooth sensors. In [16], the researchers experimented with placing the sen-
sors on the ankle, wrist or waist, and waist was selected as that was most comfortable. 
Furthermore, in [38] the device can be attached by a strap, or simply worn in a pocket, 
the latter presenting the most convenient deployment method in the review. However, 
the limitation of not being able to track limb movement, EDA or HR from this location, 
without the addition of obtrusive and invasive wires and electrodes, makes the place-
ment ideal only in situation where one is tracking full body movements and location. 
COVID 19 may also impact the choice of device for an experiment, as the need to 
reduce physical or face-to-face contact will mean that investigators may wish to choose 
a device which the participant or caregiver could simply and easily deploy themselves. 
Deployment method and duration are also vital considerations. In the BESI study the 
Pebble smartwatch is utilised to track movements of the subjects to detect agitated be-
haviours. The physiological data collection period was 30 days, with subject-carer dyad 
numbers from 3 to 10 in each study iteration [17-19]. The Pebble is worn continuously, 
which means that the participant is tracked 24/7 [19]. However, continuous deployment 
is impractical for other multi-sensor devices. These devices include the Empatica E4 
wristband, utilised in [42] to acquire accelerometry, EDA, HR and HR variability data 
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relating to dementia-related crises, over a prolonged period of time. In this study, the 
device is deployed only during the day. Therefore, the researchers may miss crises the 
subjects experience of a night. A similar device deployment pattern is utilised also in 
the DAAD study, which also uses the Empatica E4 [22, 23]. In [23], the choice of de-
ployment method is likely influenced by the collection experiment duration, with 481 
days’ of data being collected from 14 patients. Even a device with a low power-con-
sumption is unlikely to last for such periods of time. Thus, for experiments with a long 
duration, the deployment for specific times is vital. Another deployment method is de-
ploying the device for a short, specific period. This method is used in [28], where the 
Zephyr BioHarness 3.0 tracked HR in participants exhibiting PV. The belt is deployed 
for two 2-hour deployments, one being on a day when the participant experienced PVs 
and another when they did not. A similarly short duration is used in [42], where an 
android smartwatch and smartphone tracked limb movement, HR, and voice. These 
short deployment periods and short overall experimental length is thanks to observation 
of the participants prior to the data collection, allowing researchers to identify the best 
times to deploy the device. Furthermore, the participants were in the later stages of 
dementia, so their difficulties occurred more frequently due to their increased cognitive 
impairment. As such, one could argue that the more advanced participants’ stage of 
dementia the shorter experiment duration required, however this cannot be confirmed 
as many included papers do not specify participants’ stages of dementia. COVID-19 
lockdowns may limit the time that data collection can occur, with  study visits being 
lessened to reduce contact [36]. 
 
Table 1 Summary of physiological data collection methods and impact of COVID-19 
Consideration Methods/options Impacts of COVID-19 
Device type & 
placement 
Wrist-worn devices have good usability, 
sensing modalities can be less accurate. 
Chest and waist devices less convenient 
but highly accurate sensors. 
Easy to deploy devices prefer-
able as can be deployed by the 
participant or caregiver, re-
ducing human contact.  
Features moni-
tored 
Limb-worn devices track limb movement 
and whole-body, chest and waist worn de-
vices track whole-body.   
HR & EDA reliably tracked from wrist, 
could be more accurate from chest/palm.   
The choice of features moni-
tored not directly affected by 
pandemic, however features 




Shorter durations required for severe de-
mentia as difficulties more frequent.  
Longer data collection periods  used for 
people in community settings and with 
milder dementia.  
Study visits reduced due to 
need for less interaction or un-
willingness of participants or 
researchers to travel and risk 
disease.  
3.4 Observational data collection  
Observational data is a record of difficulties observed during experiments. Observa-
tional data collection methods are discussed in 16 papers. 4 different methods were 
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identified: self-reporting; caregiver observation; cameras; and combined caregiver and  
camera observation.  
Self-reporting is utilised in 2 studies [21, 43]. One of the studies focused on tracking 
and supporting situation awareness of dementia patients outdoors [43]. Each participant 
completed a mobility diary, in which they recorded details on journeys outside. The 
paper states that the information from the mobility diary had a low accuracy when com-
paring it to the activities demonstrated by the physiological data. This could suggest 
inaccuracy in self-reporting methods. Self-reporting of observations was also utilised 
in [21], with the subject similarly being asked to record on a printed weekly program 
notes about their activities, wake up times and more. No judgement is made on the 
accuracy of the self-reporting. One advantage of the use of self-reporting is that it is 
low cost [15]. Another advantage is that this method has the fewest ethical concerns of 
the 4 methods as the subject is not having their privacy compromised by other people 
[15, 45]. Moreover, this is the most COVID-secure of the methods as it requires no 
contact with the participant. However, one problem with self-reporting is that a disori-
entated or agitated participant may be incapable or unwilling to record the experienced 
difficulty [46]. Furthermore, people with mild dementia are often reluctant to admit that 
they have experienced problems beyond what is normal for an adult [47, 48], meaning 
self-reporting could be skewed to only include the most undeniable difficulties. The 
subject may also misplace the medium for self-reporting [49, 50]. 
Caregiver observation is utilised alone in 8 included papers [16-19, 24, 27, 41, 42]. 
There are two main categories: paper-based and app-based. Paper based observations 
are when the caregiver records observations on paper, in a journal [41, 42] or observa-
tion chart [24]. In [42], the caregiver recorded observed difficulties primarily with an 
event marker button on the wearable device, but were also given a journal in which to 
also record the difficulties. One reason for the journals use was that while the subject 
was experiencing difficulties, the button may be inaccessible. Also, the button could be 
accidently pressed, and the journal allowed distinction of accidental presses from gen-
uine difficulties. Finally, the journal allowed the observer to give extra context about 
difficulties, which could be invaluable to properly understand the collected data. Paper-
based recording is also used in [41], with a caregiver recording in a sleep diary the 
participant’s sleep patterns. The diary was accurate as a strong correlation was found 
between the information in the diary and the physiological data. However, the infor-
mation recorded in the diary is simple and easy to quantify and the accuracy could be 
reduced if the information recorded was more complicated. A printed observation chart 
is utilised for observation recording in [24], and this overcomes the difficulty of quan-
tifying behaviours inherent in the use of free-form mediums. This is achieved by the 
observer, in a 24-hour observation chart, marking specific colours for different diffi-
culties. This means that the observations for all subjects are standardised, making it 
easy to compare one with another. However, a drawback of this method is that the ob-
server may be able to record less context than if a journal or diary were used. This could 
make it more difficult to make full sense of the physiological data collected.  
App-based recording of caregiver observations is utilised in 4 papers [17-19, 27]. In 
the BESI study, the caregiver is asked to record temporal, spatial and characteristic 
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observations about agitation episodes that they observe, using a daily survey in an An-
droid app. No information is given on the exact nature of the survey which makes eval-
uating it difficult [17-19]. An Android app is also used in [27], with the observer re-
cording difficulties by selecting from a predetermined list. This is quick and easy for 
the observer, allowing them to record observations in a timely manner. Furthermore, 
predetermined options make the observations standardised and understandable.  
Another consideration for use of caregivers is if the caregiver is informal or formal. 
Informal caregivers (ICs) are family or friends of the participant, who care for them in 
a non-professional role. Formal caregivers (FCs) care for the participant  professionally. 
FCs, as utilised in [24, 27, 42], are trained professionals and so are more likely to un-
derstand and communicate their observations using accepted medical terms, meaning 
their observations have a higher likelihood of being standardised and understood [51]. 
Furthermore, FCs will likely better understand the difficulties and when they are oc-
curring than an IC, as FCs tend to care for multiple patients over their professional life. 
Moreover, FCs are likely to be available for long periods in institutional settings, where 
subjects are more likely to have moderate to severe dementia [52, 53]. Alternatively, 
ICs –used in [17-19, 41]- are more likely to be caring for the participant dementia in a 
home setting, as in [41] where the caregiver is the subject’s sister. This means ICs are 
likely available to observe participants for extended periods. However, ICs are highly 
susceptible to stress and burden resulting from caregiving responsibilities [54, 55]. 
Moreover, COVID-19 may restrict time ICs can spend with the participant. In institu-
tional settings, PCs may be in contact with participants for long periods, but likely care 
for multiple residents [36]. ICs who reside with participants may be able to spend more 
time with them, and where they cohabitate, the method is relatively COVID-secure.  
Cameras are utilised alone in 2 included papers [28, 39]. In [39], cameras are set up 
in a mock waiting room where participants complete tasks, with the recording being 
later analysed to identify the types and durations of behaviours exhibited by partici-
pants. The preliminary results of the study suggest a correlation between the observa-
tion and physiological data, supporting the use of cameras in such settings. Their use is 
further supported in [28], where the cameras were used to record subjects on a day when 
they experienced PVs and a day they did not. The video was then put into analysis 
software and matched with the physiological data, with great accuracy. One major ad-
vantage of cameras is that the videos can be re-watched and the observations refined, 
increasing accuracy [22]. Furthermore, as recording of video is passive this method 
does not increase burden on participants or caregivers. Moreover, cameras require no 
interaction with participants, thus are COVID-secure. However, cameras have privacy 
concerns. As such, the use of cameras should be limited to shared spaces and avoided 
in private areas [23]. Another disadvantage of cameras is the cost [15].  
A combination of caregivers and cameras is utilised in 4 of the papers included in 
the review [22, 23, 25, 26]. Two of those papers are from the DAAD study [22, 23]. In 
these studies, the caregivers recorded the agitation episodes in observational charts, 
highlighting when agitation occurred and recording the location and context. Simulta-
neously, cameras recorded the behaviours of the person with dementia in shared spaces 
in the care facility, and the recorded clips were later used to check and refine the initial 
observations. A similar combination was utilised in [25], with the researchers videoing 
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the subjects behaviours in the care facilities’ shared spaces as a FC also recorded their 
observations on an observation chart. As the cameras were to be used in a shared space 
in the institution it was necessary for all who use that space to consent. One staff mem-
ber in one home did not consent due to privacy concerns and thus cameras were not 
used there [25]. Similar privacy concerns are discussed in [26], in which the same com-
bination is used. However, the authors mitigate the privacy concerns by limiting access 
to the recordings to 2 qualified, necessary individuals. This protects the privacy of the 
participant and informing them of it could allay concerns and increase the likelihood of 
them agreeing to participate. However, if consent is not given for the use of cameras 
despite this, caregivers can still gather valuable observational data.  
 
Table 2 Summary of observational data collection methods and impacts of COVID-19. 
Consideration Methods/options Impacts of COVID-19 
Observer Self-reporting cheap and COVID-secure 
but can lack accuracy. 
FCs accurate but lower availability while 
ICs less accurate but more availability.  
Cameras are accurate however have ex-
pense and privacy concerns.  
FCs may not be able to attend or 
be with the participant due to in-
creased risk of virus.  
Cameras and self-reporting are 
COVID-secure. methods as they 
require no human interaction. 
Recording me-
dium  
Paper-based methods allow context, have 
low cost and are easy to use.  
App-based methods can be more conven-
ient for the observer.  
FCs likely to have less time with 
patient so app-based methods 
with predefined answers prefer-
rable.  
3.5 Data transfer & storage 
There are 2 methods identified for inclusion for the storage of physiological data. In 7 
of the papers included in the review, the data is stored locally on the wearable’s internal 
memory as it is collected and then transfer later. In 3 of these papers, the data is trans-
ferred from the device on to a computer. In 4 of the papers, the data is transferred on 
from the computer onto an online or cloud service. Both methods are potentially limited 
by COVID 19, as the devices would need to have a wired connection established to a 
computer. The investigators physically removing the smartwatch would require strict 
COVID-secure measures such as mask wearing and hand washing before and after han-
dling the devices [56, 57]. Alternatively, participant or caregiver could upload the data, 
however this may require them to have certain computer competencies and be ham-
pered by some devices requiring licenced software do so [58].  
Another method for storing the data is to have it transfer automatically, via wireless 
connectivity, to an edge device or a computer or server. In the BESI study, the data is 
transferred via Bluetooth to room level nodes set up in the experimental environment, 
and these edge computing devices send the data on to a server where it is stored [17-
19]. In [38], the data is temporarily stored on the Bluetooth anchors and then sent to a 
server via Wi-Fi, while in [40], the data is transferred to a base station which then sends 
the data onwards to cloud-based storage. The storage of the data locally on the device 
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for later transfer to a computer needs little environmental infrastructure and can lead to 
extended battery life. However, it also means an increased workload for the researcher 
or caregiver who downloads the data. Wireless transfer of the data to edge computing 
devices or servers means reduced workloads for researchers and is useful where the 
data collection is to be continuous for prolonged periods. It is also the most COVID-
secure method of data transfer, requiring little contact with the participants. However, 
this method requires the implementation of more infrastructure, which can increase the 
complexity and cost of the experiment [17-19]. Transfer of data to cloud-based services 
can allow for storage of large amounts of data  [26]. However, online and cloud re-
sources must be secured with access limited to authorised personnel. 
 
Table 3 Summary of methods and COVID-19 considerations. 
Experimental 
stage  
Methods  COVID-19 Considerations  
Recruitment  Hospitals and support groups best channels 
for people with mild to moderate dementia. 
Care homes best recruitment channel for 
moderate to severe dementia.   
 
Reduced hospital services and 
fewer diagnoses of dementia. 
Care homes and hospitals are 





If participant has the capacity, the partici-
pant should give written informed consent.  
If participant does not have capacity, assent 
should still be obtained but written, in-
formed consent gained from legal guardian.  
 
Difficult to reach the participants 
and get consent.  
May be more difficult for guard-
ians or next of kin to discuss 





Position of one or multiple wearables can 
be on various body parts and depends heav-
ily on the difficulty being tracked.  
Longer duration of data collection required 
for participants in earlier stages; they may 
exhibit difficulties less frequently. 
 
Set-up or deployment of devices 
is more difficult to do in 
COVID-secure manner.  
Participants may be less willing 





Self-reporting best for early stages of the 
disease. Can be unreliable.   
Caregiver observation is more reliable than 
self-reporting but is impractical in data col-
lection experiments of longer duration.  
Cameras reliable but privacy concerns. 
 
Self-reporting and cameras 
COVID-secure as no increased 
contact required. Formal care-
givers may have less time to ob-




Storing data locally on device has less in-
frastructure. Best for short experiments. 
Data streaming has increased set-up. Best 
for use in long experiments.  
COVID-secure upload of data 
stored locally more difficult. 
Data streaming most COVID-
secure as least interaction  
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4 Conclusion  
In conclusion, there are many considerations at each stage of the experimental process, 
with each being given extra weight and limitations thanks to the COVID-19 epidemic. 
It is important that accurate and reliable physiological and observational data are col-
lected, however participant confidentiality and dignity must be always retained, espe-
cially where the participant is vulnerable. Furthermore, dementia sufferers are a group 
highly impacted by COVID-19, being some one of the most likely to contract the virus, 
be isolated from support, and have increased risk of mortality. All of this should mean 
any experiments during the pandemic have minimal contact and risk of transmission. 
Overall, though a data collection experiment is possible during the pandemic, there are 
extra considerations which may make it impractical for many researchers.  
Future work could aim to understand the impact of COVID-19 on data collection 
experiments in other domains, especially domains in which the participants have 
heighten risk of mortality COVID-19. Work could also focus on the collection of a 
physiological dataset from people with dementia, which can be used to identify the 
occurrences of difficulties. Such a dataset could then be used to develop a system that 
could detect and predict the difficulties and automatically provide a digital intervention, 
reducing caregiver burden and increasing patient independence and QoL.  
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